Nur Ink Innovations Ltd (TLV:NURI)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
814.40
-38.30 (-4.49%)
Mar 30, 2026, 5:24 PM IDT

Nur Ink Innovations Income Statement

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
0.330.25---
Revenue Growth (YoY)
29.25%----
Cost of Revenue
1.611.30.060.080.14
Gross Profit
-1.29-1.04-0.06-0.08-0.14
Selling, General & Admin
3.944.083.654.964.08
Research & Development
3.584.448.776.453.07
Amortization of Goodwill & Intangibles
--0.59--
Operating Expenses
7.528.5313.0111.417.15
Operating Income
-8.81-9.57-13.07-11.5-7.29
Interest Expense
-0.63-0.35-0.37-0.4-0.48
Interest & Investment Income
-0.250.540.2-
Currency Exchange Gain (Loss)
--00.030.08-
Other Non Operating Income (Expenses)
0.02----
EBT Excluding Unusual Items
-9.42-9.67-12.86-11.61-7.77
Gain (Loss) on Sale of Assets
-----0.01
Pretax Income
-9.42-9.67-12.86-11.61-7.78
Net Income
-9.42-9.67-12.86-11.61-7.78
Net Income to Common
-9.42-9.67-12.86-11.61-7.78
Shares Outstanding (Basic)
76554
Shares Outstanding (Diluted)
76554
Shares Change (YoY)
19.68%8.93%0.18%17.73%34.29%
EPS (Basic)
-1.42-1.75-2.53-2.29-1.81
EPS (Diluted)
-1.42-1.75-2.53-2.29-1.81
Free Cash Flow
-7.87-7.13-10.17-8.09-9.12
Free Cash Flow Per Share
-1.19-1.29-2.00-1.59-2.12
Operating Margin
-2692.97%-3781.82%---
Profit Margin
-2879.51%-3820.16%---
Free Cash Flow Margin
-2407.03%-2817.00%---
EBITDA
-6.99-9.05-12.57-10.47-6.62
D&A For EBITDA
1.820.520.51.030.67
EBIT
-8.81-9.57-13.07-11.5-7.29
Source: S&P Global Market Intelligence. Standard template. Financial Sources.